Environment and People: As data is gathered to support the fit-for-purpose claim in regard to the materials and equipment, other external driving forces are introduced into the total process: environment and people. It is important to understand that the environment can significantly impact the container closure integrity of a sterile packaging system, even if the…
Fuji Pharma Takes a Stake in Biopharmaceutical Company Alvotech
Biopharmaceutical company Alvotech announced today that Japan-based Fuji Pharma has acquired a 4.2 percent stake in the business for approximately $50 million. Alvotech and Fuji Pharma recently announced an exclusive agreement for development and commercialization of biosimilars in Japan. Key shareholders in Alvotech now are Aztiq Pharma AB, which is the controlling shareholder led by…
CDMO Recipharm Partnership Aims to Advance ADHD Treatment in U.S. Market
CDMO Recipharm has entered into an agreement with Swedish life science company OnDosis for the formulation development of a treatment for attention deficit hyperactivity disorder (ADHD) in the U.S. market. Although there is no cure for ADHD, currently available treatments may help reduce symptoms and improve functioning, according to the National Institute of Mental Health (NIMH). ADHD is commonly treated…
Cambrex Expands Analytical Capabilities at Its High Point, NC Site
Lonza to Establish Key Biomanufacturing Base in China
Construction Begins on Large Biomanufacturing Facility in Ireland
WuXi Biologics, a global open-access biologics technology platform company, announced that the construction of new biologics drug substance manufacturing facility has commenced on the Industrial Development Authority’s (IDA) greenfield site in Mullagharlin, Dundalk, Co. Louth in Ireland. It’s the company’s first site outside of China and is supported by the Irish government through IDA Ireland. The facility is designed to run both…
Chinese Drugmaker to Expand Production of Polysaccharides and Enzyme Drugs
Mesa Biotech Opens Manufacturing Facility to Meet Flu Diagnosis Needs
AGC to Acquire Synthetic Pharmaceutical Active Ingredient Manufacturing Plant in Spain
AGC Inc., a manufacturer of glass, chemicals, and high-tech materials, has entered into an agreement with Boehringer Ingelheim to acquire Malgrat Pharma Chemicals S.L.U. (MPC), a subsidiary of Boehringer Ingelheim that manufactures synthetic pharmaceutical active ingredients for the group. By acquiring MPC, AGC will have its first FDA-registered site in Europe in the synthetic pharmaceutical CDMO business. The deal…
